Jacqueline Barry | Chief Clinical Officer
Cell and Gene Therapy Catapult

Jacqueline Barry, Chief Clinical Officer, Cell and Gene Therapy Catapult

Jacqueline joined Cell and Gene Therapy Catapult as Director of Regulatory Affairs and has since been promoted to Chief Clinical Officer.

Prior to this Jacqueline worked at the Scottish National Blood Transfusion Service in a number of senior regulatory and quality positions, the responsibility for which included designing the regulatory strategy for the Cellular Therapies developed by the Blood Transfusion Service, acting as Responsible Person for Blood and Qualified Person for medicinal product release. Before that she held a number of post-Doctoral academic posts at the University of Edinburgh studying neuromuscular regeneration. She has considerable experience in the development, translation, clinical trial and approval of cell based medicinal products and therapies.


15th May Pre-Conference Workshops and Summits Day @ 15:00

Clinical trial focus workshop: What needs to be done to get these experimental treatments to patients in the clinic?

· Centralized and decentralized models· Sourcing starting material: apheresis, tumor, bone marrow· From manufacture to back into local environment· Design of clinical trial

Conference Day 1: Thursday 16th May 2019 @ 14:10

Chair's opening remarks

Conference Day 1: Thursday 16th May 2019 @ 16:25

Panel discussion: Advanced Therapies Treatment Network: facilitating adoption, proof of adoption and how we get there, challenges and adoption

- What are your challenges?
last published: 21/Mar/19 09:25 GMT

back to speakers

There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.

There is a registration fee to attend the conferences. To visit the exhibition is free.


Erica Baeta 
+44 (0)207 092 1152 


Jessica Robinson 
t/ +44 (0)207 092 1150 


Issa Mauthoor 
+44 (0)207 092 1257